Page last updated: 2024-09-03

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and lj 529

n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine has been researched along with lj 529 in 5 studies

Compound Research Comparison

Studies
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Trials
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Recent Studies (post-2010)
(n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine)
Studies
(lj 529)
Trials
(lj 529)
Recent Studies (post-2010) (lj 529)
2145581203

Protein Interaction Comparison

ProteinTaxonomyn(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine (IC50)lj 529 (IC50)
Adenosine receptor A3Homo sapiens (human)0.0006

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chun, MW; Gao, ZG; Gunaga, P; Jacobson, KA; Jeong, LS; Jin, DZ; Kim, HO; Kim, YC; Melman, N; Moon, HR; Shin, DH1
Choe, SA; Choi, WJ; Gao, ZG; Hou, X; Jacobson, KA; Jeong, LS; Kim, HO; Klutz, AM; Lee, HW; Lee, SK; Moon, HR; Pal, S; Tosh, DK1
Chinn, M; Choi, WJ; Gao, ZG; Jacobson, KA; Jeong, LS; Jung, YH; Kim, HO; Lee, HW; Moon, HR; Patel, A1
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J1
Ahn, S; An, S; Choi, H; Jeong, LS; Ko, H; Noh, M; Pyo, JJ; Shin, JC; Yu, J1

Other Studies

5 other study(ies) available for n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine and lj 529

ArticleYear
N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
    Journal of medicinal chemistry, 2003, Aug-28, Volume: 46, Issue:18

    Topics: Adenosine; Animals; Cerebral Cortex; CHO Cells; Corpus Striatum; Cricetinae; Humans; Ligands; Purinergic P1 Receptor Agonists; Radioligand Assay; Rats; Receptor, Adenosine A3; Structure-Activity Relationship; Thionucleosides

2003
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
    Journal of medicinal chemistry, 2008, Oct-23, Volume: 51, Issue:20

    Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Humans; Molecular Structure; Rats; Receptor, Adenosine A3; Structure-Activity Relationship; Thionucleosides

2008
Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists.
    Bioorganic & medicinal chemistry, 2009, Dec-01, Volume: 17, Issue:23

    Topics: Adenosine A3 Receptor Agonists; Amides; Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Kinetics; Magnetic Resonance Spectroscopy; Radioligand Assay; Spectrometry, Mass, Fast Atom Bombardment; Thionucleosides

2009
Polypharmacology of N
    Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

    Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3

2017
Selenium bioisosteric replacement of adenosine derivatives promoting adiponectin secretion increases the binding affinity to peroxisome proliferator-activated receptor δ.
    Bioorganic & medicinal chemistry, 2020, 01-01, Volume: 28, Issue:1

    Topics: Adenosine; Adiponectin; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mesenchymal Stem Cells; Molecular Docking Simulation; Molecular Structure; PPAR delta; Selenium; Structure-Activity Relationship

2020